Longeveron Inc. (NASDAQ:LGVN – Free Report) CFO James Clavijo sold 5,000 shares of the stock in a transaction dated Thursday, June 29th. The shares were sold at an average price of $3.51, for a total transaction of $17,550.00. Following the transaction, the chief financial officer now owns 47,303 shares of the company’s stock, valued at […]
Operator: Good morning, and welcome to Longeveron s call today to discuss the company s 2023 First Quarter and Financial Results. All participants are currently in listen-only mode.
12.05.2023 - - New long-term survival data disclosed from ELPIS I trial of Lomecel-BTM for Hypoplastic Left Heart Syndrome; Data reinforce potential mortality benefit - - First patient dosed in Phase 2 clinical trial of Lomecel-BTM for Aging-Related Frailty .
Form 8-K Longeveron Inc For: Jan 06 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.